Stocks and Investing Stocks and Investing
Mon, October 9, 2023
Fri, October 6, 2023

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $70 on, Oct 6th, 2023


Published on 2024-10-28 06:46:10 - WOPRAI, Yigal Nochomovitz
  Print publication without navigation


Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $54 to $70 on, Oct 6th, 2023.

Yigal has made no other calls on APLS in the last 4 months.



There are 9 other peers that have a rating on APLS. Out of the 9 peers that are also analyzing APLS, 2 agree with Yigal's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Cheng of "B of A Securities" Maintained at Hold with Increased Target to $43 on, Friday, September 8th, 2023
  • Laura Chico of "Wedbush" Reiterated at Hold and Held Target at $29 on, Wednesday, August 23rd, 2023


These are the ratings of the 7 analyists that currently disagree with Yigal


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $82 on, Tuesday, September 26th, 2023
  • Derek Archila of "Wells Fargo" Upgraded from Hold to Buy and Increased Target to $64 on, Friday, September 15th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $60 on, Wednesday, August 30th, 2023
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $65 on, Tuesday, August 29th, 2023
  • Justin Kim of "Oppenheimer" Reiterated at Buy on, Wednesday, August 23rd, 2023
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $64 on, Wednesday, August 23rd, 2023
  • Colleen Kusy of "Baird" Maintained at Buy with Decreased Target to $70 on, Tuesday, August 1st, 2023

Contributing Sources